PALO ALTO, Calif., Sept. 16, 2011 /PRNewswire/ — Jazz
Pharmaceuticals, Inc. (Nasdaq:
JAZZ) announced today that the company will make a presentation
at the UBS Global Life Sciences Conference in New York on Tuesday,
September 20, 2011 at 9:30 a.m. Eastern Time. Company management
will provide a business and financial update.
A live webcast of the presentation may be accessed from the
Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.
Please connect to the website prior to the start of the conference
call to ensure adequate time for any software downloads that may be
necessary to listen to the webcast.
An archived version of webcast will be available for at least
one week on the Investors section of the company’s website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals, Inc. (Nasdaq:
JAZZ) is a specialty pharmaceutical company that identifies,
develops and commercializes innovative treatments for important,
underserved markets in neurology and psychiatry. For further
information, see www.jazzpharmaceuticals.com.